OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Potent Bispecific Neutralizing Antibody Targeting Glycoprotein B and the gH/gL/pUL128/130/131 Complex of Human Cytomegalovirus
Hang Su, Xiaohua Ye, Daniel C. Freed, et al.
Antimicrobial Agents and Chemotherapy (2021) Vol. 65, Iss. 3
Open Access | Times Cited: 17
Hang Su, Xiaohua Ye, Daniel C. Freed, et al.
Antimicrobial Agents and Chemotherapy (2021) Vol. 65, Iss. 3
Open Access | Times Cited: 17
Showing 17 citing articles:
Engineering SARS-CoV-2 specific cocktail antibodies into a bispecific format improves neutralizing potency and breadth
Zhiqiang Ku, Xuping Xie, Jianqing Lin, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 35
Zhiqiang Ku, Xuping Xie, Jianqing Lin, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 35
Targeting herpesvirus entry complex and fusogen glycoproteins with prophylactic and therapeutic agents
L. Zhong, Wanlin Zhang, Claude Krummenacher, et al.
Trends in Microbiology (2023) Vol. 31, Iss. 8, pp. 788-804
Open Access | Times Cited: 19
L. Zhong, Wanlin Zhang, Claude Krummenacher, et al.
Trends in Microbiology (2023) Vol. 31, Iss. 8, pp. 788-804
Open Access | Times Cited: 19
Recent Progress in the Discovery and Development of Monoclonal Antibodies against Viral Infections
Pardis Mokhtary, Zeinab Pourhashem, Akram Abouei Mehrizi, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1861-1861
Open Access | Times Cited: 22
Pardis Mokhtary, Zeinab Pourhashem, Akram Abouei Mehrizi, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1861-1861
Open Access | Times Cited: 22
Generation and characterization of neutralizing antibodies against M1R and B6R proteins of monkeypox virus
Yuanyuan Qu, Wanbo Tai, Enhao Ma, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Yuanyuan Qu, Wanbo Tai, Enhao Ma, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Structural basis for HCMV Pentamer recognition by neuropilin 2 and neutralizing antibodies
Daniel Wrapp, Xiaohua Ye, Zhiqiang Ku, et al.
Science Advances (2022) Vol. 8, Iss. 10
Open Access | Times Cited: 17
Daniel Wrapp, Xiaohua Ye, Zhiqiang Ku, et al.
Science Advances (2022) Vol. 8, Iss. 10
Open Access | Times Cited: 17
Novel monoclonal antibody-based therapies: implications for the treatment and prevention of HCMV disease
Marcos Nuévalos, Estéfani García‐Ríos, Francisco J. Mancebo, et al.
Trends in Microbiology (2023) Vol. 31, Iss. 5, pp. 480-497
Closed Access | Times Cited: 10
Marcos Nuévalos, Estéfani García‐Ríos, Francisco J. Mancebo, et al.
Trends in Microbiology (2023) Vol. 31, Iss. 5, pp. 480-497
Closed Access | Times Cited: 10
Human cytomegalovirus: pathogenesis, prevention, and treatment
Zifang Shang, Xin Li
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 2
Zifang Shang, Xin Li
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 2
A fully human neutralizing monoclonal antibody targeting a highly conserved epitope of the human cytomegalovirus glycoprotein B
Miwa Okamoto, Rika Kurino, Ryu Miura, et al.
PLoS ONE (2023) Vol. 18, Iss. 5, pp. e0285672-e0285672
Open Access | Times Cited: 5
Miwa Okamoto, Rika Kurino, Ryu Miura, et al.
PLoS ONE (2023) Vol. 18, Iss. 5, pp. e0285672-e0285672
Open Access | Times Cited: 5
Recent progress in development of monoclonal antibodies against human cytomegalovirus
Xiaohua Ye, Zhiqiang Ku, Ningyan Zhang, et al.
Current Opinion in Virology (2021) Vol. 52, pp. 166-173
Closed Access | Times Cited: 12
Xiaohua Ye, Zhiqiang Ku, Ningyan Zhang, et al.
Current Opinion in Virology (2021) Vol. 52, pp. 166-173
Closed Access | Times Cited: 12
The Pentamer glycoprotein complex inhibits viral Immediate Early transcription during Human Cytomegalovirus infections
Michael Ohman, Emily R. Albright, Christopher B. Gelbmann, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 39
Open Access | Times Cited: 1
Michael Ohman, Emily R. Albright, Christopher B. Gelbmann, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 39
Open Access | Times Cited: 1
Engineering SARS-CoV-2 cocktail antibodies into a bispecific format improves neutralizing potency and breadth
Zhiqiang Ku, Xuping Xie, Jianqing Lin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 7
Zhiqiang Ku, Xuping Xie, Jianqing Lin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 7
Relationship of human cytomegalovirus‐infected endothelial cells and circulating leukocytes in the pathogenesis of disseminated human cytomegalovirus infection: A narrative review
Giuseppe Gerna, Daniele Lilleri, Chiara Fornara, et al.
Reviews in Medical Virology (2023) Vol. 34, Iss. 1
Open Access | Times Cited: 3
Giuseppe Gerna, Daniele Lilleri, Chiara Fornara, et al.
Reviews in Medical Virology (2023) Vol. 34, Iss. 1
Open Access | Times Cited: 3
Cross Strain Protection against Cytomegalovirus Reduces DISC Vaccine Efficacy against CMV in the Guinea Pig Model
K. Yeon Choi, Nadia S. El‐Hamdi, Alistair McGregor
Viruses (2022) Vol. 14, Iss. 4, pp. 760-760
Open Access | Times Cited: 5
K. Yeon Choi, Nadia S. El‐Hamdi, Alistair McGregor
Viruses (2022) Vol. 14, Iss. 4, pp. 760-760
Open Access | Times Cited: 5
Evaluation of Bispecific T-Cell Engagers Targeting Murine Cytomegalovirus
Hanna Menschikowski, Christopher Bednar, Sabrina Kübel, et al.
Viruses (2024) Vol. 16, Iss. 6, pp. 869-869
Open Access
Hanna Menschikowski, Christopher Bednar, Sabrina Kübel, et al.
Viruses (2024) Vol. 16, Iss. 6, pp. 869-869
Open Access
Ligands and receptors in human cytomegalovirus entry: Current therapies and new directions
Min Zhang, Xiaochen Wang, Jianshe Li, et al.
Drug Discovery Today (2023) Vol. 29, Iss. 1, pp. 103833-103833
Closed Access | Times Cited: 1
Min Zhang, Xiaochen Wang, Jianshe Li, et al.
Drug Discovery Today (2023) Vol. 29, Iss. 1, pp. 103833-103833
Closed Access | Times Cited: 1
Structural basis for HCMV Pentamer recognition by antibodies and neuropilin 2
Daniel Wrapp, Xiaohua Ye, Zhiqiang Ku, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 3
Daniel Wrapp, Xiaohua Ye, Zhiqiang Ku, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 3
Viral and Cellular Factors Contributing to the Hematogenous Dissemination of Human Cytomegalovirus via Polymorphonuclear Leukocytes
Berenike Braun, Kerstin Laib Sampaio, Anna K. Kuderna, et al.
Viruses (2022) Vol. 14, Iss. 7, pp. 1561-1561
Open Access | Times Cited: 2
Berenike Braun, Kerstin Laib Sampaio, Anna K. Kuderna, et al.
Viruses (2022) Vol. 14, Iss. 7, pp. 1561-1561
Open Access | Times Cited: 2
